UnknownNot Applicable

Observational Study of Analgesia and Cost-efficiency of Analgetic Medication Pumps (Zalviso and PCA-syringe Pump (PCA=Patient Controlled Analgesia)) After Urogenital Intervention at the Clinical Daily Routine

Germany100 participantsStarted 2017-11-01

Plain-language summary

The observational study will check if there is a difference in the postoperative care of patients with urogenital intervention while using the standard PCA-syringe pump or using the Zalviso sufentanyl sublingual analgetic system. The study will exactly examine, using questionaire for the patient, the medical stuff (nurses and anesthesiologist) the difference in the analgetic quality, the difference of the patients' mobility while being treated with one of the analgetic system and if there is a difference in the cost-efficiency. We want to examine 50 Patients in each group. The studies should be finished in about one year.

Who can participate

Age range18 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients after urological interventions with no indication of an periduralanästesia * Patients compliant for a PCA system, and complied with the analysis of their data Exclusion Criteria: * F03 dementia * F10.2 dependence syndrome alcohol * F11.2 dependence syndrome opioids * F12.2 dependence syndrome cannabinoids * F13.2 dependence syndrome sedatives and hypnotics * F14.2 dependence syndrome cocaine * F15.2 dependence syndrome coffin * F.16.2 dependence syndrome hallucinogens * F22 schizophrenia * F41.1 generalized anxiety disorder

What they're measuring

analgesic quality

Timeframe: 1 year

mobility

Timeframe: 1 year

Trial details

NCT IDNCT03355352

SponsorUniversity Hospital Tuebingen

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2018-08-01

Contact for this trial

Barbara Schlisio, Dr. med.

07071/2985612 barbara.schlisio@med.uni-tuebingen.de